Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001279569-13-000509
Filing Date
2013-04-18
Accepted
2013-04-18 13:29:23
Documents
7
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A v341788_20fa.htm 20-F/A 31201
  Complete submission text file 0001279569-13-000509.txt   4761375

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT crme-20121231.xml EX-101.INS 741196
3 XBRL TAXONOMY EXTENSION SCHEMA crme-20121231.xsd EX-101.SCH 59715
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crme-20121231_cal.xml EX-101.CAL 48310
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crme-20121231_def.xml EX-101.DEF 231246
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE crme-20121231_lab.xml EX-101.LAB 429134
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crme-20121231_pre.xml EX-101.PRE 314063
Mailing Address 6TH FLOOR 6190 AGRONOMY RD. VANCOUVER A1 V6T 1Z3
Business Address 6TH FLOOR 6190 AGRONOMY RD. VANCOUVER A1 V6T 1Z3 1-604-677-6905
Cardiome Pharma Corp (Filer) CIK: 0001036141 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 000-29338 | Film No.: 13768807
SIC: 2834 Pharmaceutical Preparations